Literature DB >> 16537381

Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.

Deborah N Chadee1, Dazhong Xu, Gene Hung, Ali Andalibi, David J Lim, Zhijun Luo, David H Gutmann, John M Kyriakis.   

Abstract

The Ras --> Raf --> MEK1/2 --> extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway couples mitogenic signals to cell proliferation. B-Raf and Raf-1 function within an oligomer wherein they are regulated in part by mutual transactivation. The MAPK kinase kinase (MAP3K) mixed-lineage kinase 3 (MLK3) is required for mitogen activation of B-Raf and cell proliferation. Here we show that the kinase activity of MLK3 is not required for support of B-Raf activation. Instead, MLK3 is a component of the B-Raf/Raf-1 complex and is required for maintenance of the integrity of this complex. We show that the activation of ERK and the proliferation of human schwannoma cells bearing a loss-of-function mutation in the neurofibromatosis 2 (NF2) gene require MLK3. We find that merlin, the product of NF2, blunts the activation of both ERK and c-Jun N-terminal kinase (JNK). Finally, we demonstrate that merlin and MLK3 can interact in situ and that merlin can disrupt the interactions between B-Raf and Raf-1 or those between MLK3 and either B-Raf or Raf-1. Thus, MLK3 is part of a multiprotein complex and is required for ERK activation. The levels of this complex may be negatively regulated by merlin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537381      PMCID: PMC1450194          DOI: 10.1073/pnas.0510651103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Merlin and ERM proteins: unappreciated roles in cancer development?

Authors:  Andrea I McClatchey
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

2.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

3.  Inducible gene deletion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor signalling.

Authors:  Tilman Brummer; Peter E Shaw; Michael Reth; Yukiko Misawa
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

4.  The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

Authors:  R J Shaw; J G Paez; M Curto; A Yaktine; W M Pruitt; I Saotome; J P O'Bryan; V Gupta; N Ratner; C J Der; T Jacks; A I McClatchey
Journal:  Dev Cell       Date:  2001-07       Impact factor: 12.270

5.  Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2.

Authors:  Gene Hung; Xiankui Li; Rodolfo Faudoa; Zhu Xeu; Lan Kluwe; Johng S Rhim; William Slattery; David Lim
Journal:  Int J Oncol       Date:  2002-03       Impact factor: 5.650

Review 6.  Mixed-lineage kinase control of JNK and p38 MAPK pathways.

Authors:  Kathleen A Gallo; Gary L Johnson
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 7.  Raf proteins and cancer: B-Raf is identified as a mutational target.

Authors:  Kathryn E Mercer; Catrin A Pritchard
Journal:  Biochim Biophys Acta       Date:  2003-06-05

8.  Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.

Authors:  Chun-Xiao Sun; Carrie Haipek; Daniel R Scoles; Stefan M Pulst; Marco Giovannini; Masayuki Komada; David H Gutmann
Journal:  Hum Mol Genet       Date:  2002-12-01       Impact factor: 6.150

Review 9.  Neurofibromatosis 2.

Authors:  Michael E Baser; D Gareth R Evans; David H Gutmann
Journal:  Curr Opin Neurol       Date:  2003-02       Impact factor: 5.710

10.  Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.

Authors:  Juergen-Theodor Fraenzer; Huiqi Pan; Lauro Minimo; George M Smith; Dan Knauer; Gene Hung
Journal:  Int J Oncol       Date:  2003-12       Impact factor: 5.650

View more
  47 in total

Review 1.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

2.  Metabolic stress signaling mediated by mixed-lineage kinases.

Authors:  Anja Jaeschke; Roger J Davis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 3.  Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns.

Authors:  F J Wippold; M Lubner; R J Perrin; M Lämmle; A Perry
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

4.  The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.

Authors:  Katherine Striedinger; Scott R VandenBerg; Gilson S Baia; Michael W McDermott; David H Gutmann; Anita Lal
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

5.  Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.

Authors:  Maurits de Vries; Inge Briaire-de Bruijn; Anne-Marie Cleton-Jansen; Martijn J A Malessy; Andel G L van der Mey; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2012-12-08       Impact factor: 4.064

6.  The phosphorylation status of merlin in sporadic vestibular Schwannomas.

Authors:  Zhaoyan Wang; Yanjun Lu; Juanjuan Tang; Haojie Wang; Hao Wu
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

7.  MLK3 limits activated Galphaq signaling to Rho by binding to p63RhoGEF.

Authors:  Katherine I Swenson-Fields; Joshua C Sandquist; Jessica Rossol-Allison; Irene C Blat; Krister Wennerberg; Keith Burridge; Anthony R Means
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

8.  NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation.

Authors:  E E Bosco; Y Nakai; R F Hennigan; N Ratner; Y Zheng
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

9.  p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.

Authors:  Hoi Yee Chow; Dina Stepanova; Jennifer Koch; Jonathan Chernoff
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

10.  Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours.

Authors:  Sérgia Velho; Carla Oliveira; Joana Paredes; Sónia Sousa; Marina Leite; Paulo Matos; Fernanda Milanezi; Ana Sofia Ribeiro; Nuno Mendes; Danilo Licastro; Auli Karhu; Maria José Oliveira; Marjolijn Ligtenberg; Richard Hamelin; Fátima Carneiro; Annika Lindblom; Paivi Peltomaki; Sérgio Castedo; Simó Schwartz; Peter Jordan; Lauri A Aaltonen; Robert M W Hofstra; Gianpaolo Suriano; Elia Stupka; Arsenio M Fialho; Raquel Seruca
Journal:  Hum Mol Genet       Date:  2009-12-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.